Virus infection induced pulmonary fibrosis.

Huang, Wei Jie; Tang, Xiao Xiao

Huang, Wei Jie; Tang, Xiao Xiao.

Afiliação

Huang WJ; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Tang XX; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. tangxiaoxiao@gird.cn.

J Transl Med ; 19(1): 496, 2021 12 07.

Article em En | MEDLINE | ID: mdl-34876129

Assuntos

COVID-19; Infecções por Vírus Epstein-Barr; Fibrose Pulmonar; Coronavírus Relacionado à Síndrome Respiratória Aguda Grave; Viroses; Animais; Herpesvirus Humano 4; Humanos; Camundongos; Fibrose Pulmonar/etiologia; SARS-CoV-2

Palavras-chave

Mechanisms; Potential anti-fibrotic therapy; Pulmonary fibrosis; SARS-CoV-2; Virus infection

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar / Viroses / Infecções por Vírus Epstein-Barr / Coronavírus Relacionado à Síndrome Respiratória Aguda Grave / COVID-19 Tipo de estudo: Etiology_studies Limite: Animals / Humans Idioma: En Revista: J Transl Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google